期刊文献+

中期因子基因在疾病诊断和治疗中的应用 被引量:2

Application of Midkine Gene in Diagnosis and Therapy
原文传递
导出
摘要 中期因子(midkine,MK)是一种肝素结合生长因子。与炎性疾病、肿瘤、神经病变性疾病及AIDS的发生有着重要的关系。MK在多种实体肿瘤中有高表达,可以作为肿瘤的预后指标以及多种疾病治疗的靶点。针对MK的治疗主要是应用MK的抗体、反义寡核苷酸、siRNA和一些能够与MK发生特异结合分子,其作用机制主要是抑制MK生成以及中和MK作用。作为一种肿瘤特异性启动子,MK启动子调控自杀基因也被应用于肿瘤的治疗。 Midkine (MK), a heparin-binding growth factor, plays an important role in the pathogenesis of tumor, inflammation, neurodegenerative diseases and the development of AIDS. MK can be used as a novel tumor marker and therapeutic target. As a tumor-specific promoter, MK promoter regulating suicide gene expression is efficient and specific in tumor therapy.
作者 王洋 王敏
出处 《医学分子生物学杂志》 CAS CSCD 2008年第2期149-153,共5页 Journal of Medical Molecular Biology
基金 国家高技术研究发展计划(863计划)(No.2006AA02A405) 天津市科技发展计划(No.05YFSZSF02400)~~
关键词 中期因子 实体肿瘤 反义寡核苷酸 SIRNA midkine solid tumor antisense oligonucleotides siRNA
  • 相关文献

参考文献5

二级参考文献21

共引文献39

同被引文献29

  • 1Muramatsu H,Inni T,Muramatsu T,et al. Localization of heparin-binding neurite outgrowth and antigenic regions in midkine molecule. Biochem Biophys Res Commun, 1994,203 : 1131-1139.
  • 2Ikematsu S,Yano A, Aridome K, et al. Serum midkine levels are increased in patients with various types of carcinomas. Br J Cancer, 2000,83 : 701-706.
  • 3Konishi N,Nakamura M,Nakaoka S,et al. Immunohistchemical analysis of midkine expression in human protate carcinoma. Om Cology, 1999,57 : 253-257.
  • 4Kato M,Shinozawa T,Kato S,et al. Increased midkine expression in hepatoeellular carcinoma. Aech Pathol Lab Med,2000,124: 848-852.
  • 5Muramatsu H,Shirhama H,Yonezawa S, et al. Midkine,a retinoic acidinducible growth/differetiation factor:immunochemical evidence for the function and distribution. Dev Biol, 1993,159:392-402.
  • 6Horiba M, Kadomatsu K,Yasui K, et al. Midkine plays a protective role against cardiac ischemia/reperfusion injury through a reduction of apoptotic reaction. Circulation, 2006,114 : 1713-1720.
  • 7Fukui S, Kitagawa-Sakakida S, Kawamata S, et al. Therapeutic effect of midkine on cardiac remodeling in infarcted rat hearts. Ann Thorac Surg, 2008,85 : 562-570.
  • 8Benetos A, Lacoley P. Prevention of aortic fibrosis by spironolactone in spontaneously hypertensive rights. Arteriosceler Thromb Vsc Biol, 1997,17 : 1152-1156.
  • 9Yang Y J, Tang YD, Ruan YM, et al. Comparative effects of carvedilol and losartan alone and in combination for preventing left ventricular remodeling after acute myocardial infarction in rats. Circ J,2003,67:159-162.
  • 10Cohn JN, Ferran R, Sharpe N, et al. Cardiac remodeling concepte and clinical implications:a consensus paper from an international forum on cardiac remodeling. J Am Coll Cardiol,2001,35: 569-582.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部